Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | HCAR3 | P49019 | 8/20 | 0.49 |
| ▸ | CASP6 | P55212 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL266715 | 0.89 | MEN1 (0.60) | MEN1KMT2APOLBHCAR3CASP6 | |
| SCHEMBL264276 | 0.86 | MEN1 (0.57) | MEN1KMT2APOLBMAPTGAA | |
| SCHEMBL238958 | 0.83 | MEN1 (0.68) | MEN1KMT2APOLBMAPTALDH1A1 | |
| SCHEMBL21710428 | 0.82 | KMT2A (0.66) | MEN1KMT2APOLBMAPTALDH1A1 | |
| Water SCHEMBL28099770 | 0.82 | MEN1 (0.66) | MEN1KMT2APOLBMAPTALDH1A1 | |
| SCHEMBL266107 | 0.80 | KMT2A (0.76) | MEN1KMT2APOLBCASP6MAPT | |
| SCHEMBL267326 | 0.79 | ALDH1A1 (0.52) | MEN1KMT2APOLBHCAR3MAPT | |
| Alcohol SCHEMBL28281654 | 0.79 | KMT2A (0.59) | MEN1KMT2APOLBMAPTALDH1A1 | |
| SCHEMBL272006 | 0.78 | POLB (0.61) | MEN1KMT2APOLBMAPTGAA | |
| SCHEMBL264500 | 0.78 | MEN1 (0.61) | MEN1KMT2APOLBMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1655070-B1 | OXIDATION CATALYST | ASAHI KASEI CHEMICALS CORP (JP) | 2015-07-15 | — | — | EP | disclosed |
| US-8133834-B2 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100069670-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20060229471-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2006-10-12 | — | — | US | disclosed |
| EP-1655070-A1 | OXIDATION CATALYST | Asahi Kasei Chemicals Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069670-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | MEN1 4765/4885KMT2A 1292/4885POLB 549/4885 |
| US-20060229471-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | MEN1 4765/4885KMT2A 1292/4885POLB 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.